Brazil Contraceptive Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Brazil Contraceptive Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Brazil contraceptive devices market is expected to register a CAGR of 7% over the forecast period.

The coronavirus disease (COVID-19) is a global health emergency. The COVID-19 pandemic forced many companies in the global contraceptives industry to halt business operations for a short term to comply with new government regulations to curb the spread of the disease. This halt in operations directly impacted the revenue flow of the Brazilian contraceptive device market. For instance, an article titled, ‘Comparison of contraceptive sales before and during the COVID-19 pandemic in Brazil' published in February 2022 reported that since many family planning clinics were closed, sales of most modern contraceptives fell during 2020; however, the increase in sales of the levonorgestrel-releasing intrauterine system (LNG-IUS) and etonogestrel (ENG) implant in the private sector indicated inequitable access to modern contractive methods. Further, no new consignments were received by companies operating in this sector. Hence, a halt in industrial activities and lockdowns for several months affected the Brazilian contraceptive devices industry, and Brazil's contraceptive devices market is anticipated to witness slow growth during the initial phase of the pandemic, however, the market witnessed significant growth over some time.

The factors which are driving the Brazilian contraceptive devices market are the increasing incidence of sexually transmitted diseases (STDs), and an increase in unplanned pregnancies. The increasing incidence of sexually transmitted diseases (STDs) is reported in the country and that is driving the demand for contraceptives in Brazil. Sexually transmitted infections (STIs), including syphilis, chlamydia, gonorrhea, trichomoniasis, and genital herpes, are major public health problems in Brazil. For instance, an article titled, 'Brazilian Protocol for Sexually Transmitted Infections, 2020: Infections that cause cervicitis’ published in May 2021 reported the high prevalence of sexually transmitted diseases in Brazil. The article also reported a high incidence of Chlamydia and gonorrhea infections borne infection in Brazil. In 2020, the Brazilian Institute of Geography and Statistics reported a high population of sexual infections in certain key populations such as men who have sex with men (MSM) and transgender women (TG) with much higher prevalence rates than the general population, about 48,000 new sexually transmitted infections were recorded in this country. The increasing rise in sexually transmitted diseases (STDs) is making people more aware of the risks associated with them, thereby increasing the demand for contraceptive devices. Also, governments and policymakers in the country are addressing sexually transmitted infections (STIs) among young people through high-quality sex education programs, access to clinical care, preventive technologies and vaccines, and confidential services. All these initiatives are making young people aware of sexually transmitted diseases (STDs) and thus, increasing the need for contraceptive devices, thereby driving the market.

An unintended pregnancy occurs from not using contraception or by inconsistent and incorrect use of contraceptive methods. The growth of the contraceptives markets is a necessity to avoid unwanted pregnancies and their complications, especially among teenagers. For instance, an article titled, “Risks of Adverse Neonatal Outcomes in Early Adolescent Pregnancy Using Group Prenatal Care as a Strategy for Public Health Policies: A Retrospective Cohort Study in Brazil” published in April 2021 reported that approximately 12 million adolescents aged 15–19 years and 770 thousand of whom are under 15 years give birth each year in developing world. In Brazil, the rate of adolescent pregnancy is 400 thousand cases each year. Thus, high adolescent and unplanned pregnancy may be a risk factor for sexually transmitted diseases, thereby driving the market for contraceptive devices in the country.

Therefore, due to the aforesaid mentioned reasons, the Brazil contraceptive devices market is expected to show significant growth over the forecast period. However, side effects associated with using devices may slow down the market growth over the studied period.

Key Market TrendsCondoms Segment is Expected to Witness a Significant Growth Over the Forecast Period

Condoms are expected to witness significant growth over the forecast period. Condoms are barrier contraceptives made from latex rubber, a synthetic rubber called polyisoprene, a very thin plastic called polyurethane, or a synthetic material called nitrile. Condoms are available free from contraception clinics sexual health or genitourinary medicine (GUM) clinics. A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also to a lesser extent protect against genital herpes, human papillomavirus (HPV), and syphilis. Furthermore, they are cheap and easy to use, thus they are expected to dominate the market. Also, the rise in the adoption rates of contraceptive products among consumers across the world is boosting the demand for condoms. Moreover, growing awareness through government initiatives, along with comprehensive sex education programs to reduce the prevalence of sexually transmitted diseases, is driving market growth across Brazil. Therefore, with the increasing rate of STDs, there will be a rapid increase in the demand for contraceptives, which ultimately drives the market.

In July 2022, the Brazilian Institute of Geography and Statistics reported that the group aged 30 and over-represented 56.1% of the country’s population in 2021, and the population aged less than 30 years constitute 43.9% of the population. Due to the presence of high among younger sexually active populations where chances of acquiring sexually transmitted infections (STIs) are high, the use of condoms reduces the prevalence of sexually transmitted infections (STIs) and teenage pregnancy. Also, the many government initiatives in the country are making young individuals aware of the use of condoms and the associated risks of unprotected sexual intercourse. Thus, the presence of a higher percentage of the young population in Brazil is associated with the increased use of condoms, thereby driving the studied market.

The government in the country has introduced different campaigns and comprehensive sex education programs to improve awareness among youth and encourage them to use contraceptives to combat STDs and prevent unwanted pregnancies. For instance, an article titled, ‘How Social Marketing Contributed to Expanding Size of Overall Condom Markets in Ethiopia, Brazil, and Indonesia’ published in March 2022 reported that social marketing has been used to address a variety of health issues in the global south, including the promotion and distribution of condoms for family planning and HIV prevention. The article also reported that the government of Brazil had started promoting condoms heavily with creative and striking ads on TV, radio, and other media in response to an emerging HIV epidemic. It began free distribution, in the last two decades. For another instance, in July 2020, Trojan launched New XOXO, which features packaging innovations, including a discreet mini travel pack that stores up to two condoms for added convenience while carrying on the go. Thus, due to the aforesaid mentioned reasons, the segment is expected to show significant growth over the forecast period.

Competitive Landscape

The market studied is moderately competitive and there are several international players that are operating in Brazil Contraceptive devices market. The global players in the Brazil contraceptive devices market are Allergan PLC, Bayer AG, Church & Dwight Co, Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Reckitt Benckiser Group plc, The Cooper Companies, Inc., and Veru Inc. (The Female Health Company).

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.